Kick-Off Meeting of 1st ever once weekly OAD- Omari (Omarigliptin) Clinical Trial with Endocrinologists of BIRDEM.

February 9, 2024

ACME's DiaCare has collaborated with the esteemed endocrinologists of BIRDEM for the benefits of Diabetic population of Bangladesh with the 1st ever once weekly OAD- Omari (Omarigliptin). Professor & Head of the Dept. Endocrinology Department, BIRDEM- Prof. Feroz Amin sir, Associate Professor Dr. Faria Afsana madam along with other endocrinologists and top management of The ACME Laboratories Ltd. were present on this breakthrough clinical trial kickoff meeting.